Author: | Kris, M. |
Article Title: | New approaches in the management of lung cancer |
Abstract: | The management of non-small cell lung cancer has improved markedly in past years. This article discusses the importance of translating encouraging findings into clinical practice, identifying which patients are most likely to benefit, and designing additional trials to further refine treatment options. © Journal of the National Comprehensive Cancer Network. |
Keywords: | cancer chemotherapy; cancer survival; treatment response; oncoprotein; genetics; proto-oncogene proteins; clinical trial; cancer recurrence; bevacizumab; erlotinib; antineoplastic agents; conference paper; paclitaxel; antineoplastic agent; clinical practice; carboplatin; lung non small cell cancer; lung neoplasms; epidermal growth factor receptor; smoking; receptor, epidermal growth factor; cancer research; monoclonal antibody; lung tumor; antibodies, monoclonal; drug antagonism; gefitinib; quinazolines; non-small cell lung cancer; quinazoline derivative; epidermal growth factor receptor kinase inhibitor; egfr mutation; kras gene; epidermal growth factor receptors; bronchiolar carcinoma |
Journal Title: | Journal of the National Comprehensive Cancer Network |
Volume: | 3 |
Issue: | Suppl. 1 |
ISSN: | 1540-1405 |
Publisher: | Harborside Press |
Date Published: | 2005-11-01 |
Start Page: | S22 |
End Page: | S24 |
Language: | English |
PUBMED: | 16280107 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | --- - "Cited By (since 1996): 1" - "Export Date: 24 October 2012" - "Source: Scopus" |